Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Seminars in Thrombosis and Hemostasis|March 18, 2003
A healthy hemophilic patient without arthropathy: from concept to clinical realityErik Berntorp, Jan J Michiels
Seminars in Thrombosis and Hemostasis|July 1, 2006
The role of JAK2 V617F mutation, spontaneous erythropoiesis and megakaryocytopoiesis, hypersensitive platelets, activated leukocytes, and endothelial cells in the etiology of thrombotic manifestations in polycythemia vera and essential thrombocythemiaSylvia Bellucci, Jan J Michiels
Seminars in Thrombosis and Hemostasis|April 24, 2003
Acquired thrombophilia in pregnancy: essential thrombocythemiaMartin Griesshammer, Martin Grünewald, Jan J Michiels
Seminars in Thrombosis and Hemostasis|May 7, 2002
Acquired von Willebrand syndrome: experience from 2 years in a single laboratory compared with data from the literature and an international registryUlrich Budde, Frauke Bergmann, Jan J Michiels
Seminars in Thrombosis and Hemostasis|September 16, 2006
Guidelines for the evaluation of intravenous desmopressin and von Willebrand factor/factor VIII concentrate in the treatment and prophylaxis of bleedings in von Willebrand disease types 1, 2, and 3Jan J Michiels, Alain Gadisseur, Marc van der Planken, et al.
Thrombosis and Haemostasis|September 4, 2008
PFA-100 monitoring of von Willebrand factor (VWF) responses to desmopressin (DDAVP) and factor VIII/VWF concentrate substitution in von Willebrand disease type 1 and 2Huub H D M van Vliet, Mies C Kappers-Klunne, Frank W G Leebeek, et al.
Archives of Neurology|October 12, 2005
Autosomal dominant erythermalgia associated with a novel mutation in the voltage-gated sodium channel alpha subunit Nav1.7Jan J Michiels, Rene H M te Morsche, Jan B M J Jansen, et al.
Seminars in Thrombosis and Hemostasis|September 16, 2006
The paradox of platelet activation and impaired function: platelet-von Willebrand factor interactions, and the etiology of thrombotic and hemorrhagic manifestations in essential thrombocythemia and polycythemia veraJan J Michiels, Zwi Berneman, Wilfried Schroyens, et al.
Seminars in Thrombosis and Hemostasis|July 1, 2006
The 2001 World Health Organization and updated European clinical and pathological criteria for the diagnosis, classification, and staging of the Philadelphia chromosome-negative chronic myeloproliferative disordersJan J Michiels, Hendrik De Raeve, Zwi Berneman, et al.
Seminars in Thrombosis and Hemostasis|May 5, 2006
Clinical and laboratory features, pathobiology of platelet-mediated thrombosis and bleeding complications, and the molecular etiology of essential thrombocythemia and polycythemia vera: therapeutic implicationsJan J Michiels, Zwi Berneman, Dirk Van Bockstaele, et al.
Pageof 2